What is Hepzato?: A Targeted Liver Therapy for Metastatic Uveal Melanoma
•
3 min read
Up to 90% of metastatic uveal melanoma cases are concentrated within the liver, making liver-directed therapy a critical need. **What is Hepzato?** It represents a significant advancement, offering a targeted chemotherapy delivery system to treat these unresectable liver metastases while minimizing the systemic exposure and side effects typically associated with traditional treatments.
